|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 11/07/23 Enovis Corp. 10-Q 9/29/23 74:7.4M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.43M
2: EX-10.1 Material Contract HTML 260K
3: EX-31.01 Certification -- §302 - SOA'02 HTML 27K
4: EX-31.02 Certification -- §302 - SOA'02 HTML 27K
5: EX-32.01 Certification -- §906 - SOA'02 HTML 21K
6: EX-32.02 Certification -- §906 - SOA'02 HTML 21K
12: R1 Cover Page HTML 74K
13: R2 Condensed Consolidated Statements of Income HTML 146K
14: R3 Condensed Consolidated Statements of Comprehensive HTML 65K
Income (Loss)
15: R4 Condensed Consolidated Statements of Comprehensive HTML 31K
Income (Loss) [Parenthetical]
16: R5 Condensed Consolidated Balance Sheets HTML 136K
17: R6 Condensed Consolidated Balance Sheets HTML 33K
[Parenthetical]
18: R7 Condensed Consolidated Statement of Equity HTML 99K
19: R8 Condensed Consolidated Statement of Equity HTML 25K
Statement of Stockholders' Equity [Parenthetical]
20: R9 Condensed Consolidated Statements of Cash Flows HTML 113K
21: R10 General HTML 26K
22: R11 Recently Issued Accounting Pronouncements HTML 31K
23: R12 Discontinued Operations HTML 54K
24: R13 Acquisitions and Investments HTML 33K
25: R14 Revenue HTML 57K
26: R15 Net Loss Per Share from Continuing Operations HTML 56K
27: R16 Income Taxes HTML 34K
28: R17 Equity HTML 71K
29: R18 Inventories, Net HTML 30K
30: R19 Debt HTML 52K
31: R20 Accrued Liabilities HTML 57K
32: R21 Financial Instruments and Fair Value Measurements HTML 65K
33: R22 Commitments and Contingencies HTML 24K
34: R23 Segment Information HTML 87K
35: R24 Subsequent Events HTML 25K
36: R25 Pay vs Performance Disclosure HTML 33K
37: R26 Insider Trading Arrangements HTML 26K
38: R27 Recently Issued Accounting Pronouncements HTML 29K
(Policies)
39: R28 Discontinued Operations and Disposal Groups HTML 55K
(Tables)
40: R29 Revenue (Tables) HTML 55K
41: R30 Net Loss Per Share from Continuing Operations HTML 55K
(Tables)
42: R31 Equity (Tables) HTML 69K
43: R32 Inventories, Net (Tables) HTML 31K
44: R33 Debt (Tables) HTML 30K
45: R34 Accrued Liabilities (Tables) HTML 59K
46: R35 Financial Instruments and Fair Value Measurements HTML 58K
(Tables)
47: R36 Segment Information (Tables) HTML 82K
48: R37 General (Details) HTML 22K
49: R38 Discontinued Operations - Financial Results HTML 66K
(Details)
50: R39 Discontinued Operations - Narratives (Details) HTML 28K
51: R40 Acquisitions and Investments - Narrative (Details) HTML 113K
52: R41 Revenue - Disaggregation of Revenue (Details) HTML 42K
53: R42 Revenue - Allowance for Credit Loss Rollforward HTML 31K
(Details)
54: R43 Net Loss Per Share from Continuing Operations HTML 45K
(Details)
55: R44 Net Loss Per Share from Continuing Operations - HTML 23K
Narrative (Details)
56: R45 Income Taxes (Details) HTML 31K
57: R46 Equity Textual (Details) HTML 21K
58: R47 Equity - AOCL Components (Details) HTML 65K
59: R48 Inventories, Net (Details) HTML 33K
60: R49 Debt - Components (Details) HTML 38K
61: R50 Debt -Textual (Details) HTML 141K
62: R51 Accrued Liabilities - Schedule of Accrued HTML 55K
Liabilities (Details)
63: R52 Accrued Liabilities -Restructuring Rollforward HTML 48K
(Details)
64: R53 Financial Instruments and Fair Value Measurements HTML 73K
- Narrative (Details)
65: R54 Financial Instruments and Fair Value Measurements HTML 28K
- Schedule of Effect of Designated Hedges
Instruments on Accumulated Other Comprehensive
Income (Loss) (Details)
66: R55 Financial Instruments and Fair Value Measurements HTML 53K
Derivative Instruments in Consolidated Balance
Sheet (Details)
67: R56 Financial Instruments and Fair Value HTML 34K
Measurements-Contingent Consideration Liability
(Details)
68: R57 Segment Information - Results and Reconciliation HTML 67K
of Operating Loss to Adjusted EBITDA (Details)
69: R58 Subsequent Events (Details) HTML 41K
72: XML IDEA XML File -- Filing Summary XML 127K
70: XML XBRL Instance -- cfx-20230929_htm XML 1.54M
71: EXCEL IDEA Workbook of Financial Report Info XLSX 130K
8: EX-101.CAL XBRL Calculations -- cfx-20230929_cal XML 200K
9: EX-101.DEF XBRL Definitions -- cfx-20230929_def XML 461K
10: EX-101.LAB XBRL Labels -- cfx-20230929_lab XML 1.64M
11: EX-101.PRE XBRL Presentations -- cfx-20230929_pre XML 906K
7: EX-101.SCH XBRL Schema -- cfx-20230929 XSD 144K
73: JSON XBRL Instance as JSON Data -- MetaLinks 489± 707K
74: ZIP XBRL Zipped Folder -- 0001420800-23-000030-xbrl Zip 374K
| Document |
| 1. | I have reviewed this quarterly report on Form 10-Q of Enovis Corporation; | ||||
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | ||||
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | ||||
| 4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: | ||||
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |||||||
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |||||||
| (c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |||||||
| (d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and | |||||||
| 5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): | ||||
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and | |||||||
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. | |||||||
| Matthew L. Trerotola President and Chief Executive Officer (Principal Executive Officer) | ||
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/7/23 | 8-K | ||
| For Period end: | 9/29/23 | 4 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/25/23 Enovis Corp. 8-K:1,2,3,910/19/23 13:2.7M Donnelley … Solutions/FA 9/28/23 Enovis Corp. 8-K:1,3,9 9/22/23 11:659K Donnelley … Solutions/FA 12/15/22 Enovis Corp. 8-K:5,9 12/13/22 11:406K Donnelley … Solutions/FA 4/08/22 Enovis Corp. 8-K:1,2,3,5 4/04/22 22:3.1M Donnelley … Solutions/FA 1/30/12 Enovis Corp. 8-K:1,3,9 1/24/12 7:1M Skadden/FA |